Hepatitis B is a silent killer, and every adult should know their status
Across Kenya, a virus that announces nothing is quietly determining who lives and who dies. Hepatitis B, transmitted through blood, sex, and birth, can spend years undetected before igniting liver cancer — a disease that, once visible, leaves most patients only months to live. The stories of those who survived and those who did not reveal a gap not in medical knowledge, but in political will: the surveillance programs, vaccination campaigns, and transplant infrastructure that could close the distance between diagnosis and survival remain unbuilt.
- Liver cancer kills most patients within three to six months of diagnosis, and Hepatitis B — its most common silent driver — infects thousands of Kenyans who have no idea they carry it.
- Roy died at thirty-seven within weeks of learning his diagnosis; his family hid the cause from neighbors, unable to face the stigma that trails the virus like a second disease.
- Millennials and Generation X — roughly ages 27 to 40 — largely missed Kenya's 2001 vaccination rollout, leaving an entire cohort exposed without knowing it.
- Countries like South Africa and Egypt have already built mandatory national screening programs that catch cancer early enough to operate; Kenya has trained surgeons and a transplant plan at Kenyatta National Hospital, but no nationwide program to find patients in time.
- Doctors and survivors are calling for urgent surveillance campaigns, revaccination drives, and transplant infrastructure — the tools exist, but the political commitment to deploy them at scale does not yet.
Omar wakes each morning and counts it as a small miracle. There was a time when he lived on the streets of Mombasa, when the virus entered his body without announcement — through unprotected sex or shared needles, he cannot say. What saved him was a sister with medical knowledge abroad, a family with resources, and the speed to act once the diagnosis revealed not just the virus but cancer already growing in his liver. He survived. Roy did not. At thirty-seven, Roy learned he carried Hepatitis B and understood what it meant, but fear of stigma kept him silent. By the time he told his family, the cancer had progressed beyond reach. He was dead within weeks. His family stopped telling people the true cause.
Hepatitis B spreads through blood, sexual contact, childbirth, and shared personal items like razors. It can persist for life without symptoms, a slow-burning fuse that damages the liver, sometimes leading to cirrhosis, sometimes directly to cancer. Once liver cancer develops, the prognosis is grim — most patients survive three to six months. Chemotherapy does not work here; doctors turn to immunotherapy and targeted drugs, but the window is narrow. Dr. Andrew Odhiambo, a cancer specialist at Nairobi Hospital, describes it plainly: Hepatitis B is a silent killer.
Kenya records between 900 and 1,000 new liver cancer cases each year. The national vaccination campaign launched in 2001 protected many children born from that year onward, but those now aged 27 to 40 — millennials and Generation X — largely missed it. They are the vulnerable cohort, and most do not know their status. Dr. Odhiambo notes that revaccination is safe for anyone uncertain of their immunity.
The most powerful tool available is surveillance. South Africa and Egypt have mandatory national screening programs requiring known carriers to undergo annual ultrasounds and blood tests, catching cancer early enough for surgery or transplantation. Kenya has no liver transplant program yet, though Kenyatta National Hospital has trained surgeons and has begun planning one. What remains missing is the nationwide will — to test the population, to find who carries the virus, and to build the infrastructure that could turn an early diagnosis into a life saved rather than a death delayed.
Omar wakes each morning in clean sheets and counts it as a small miracle. There was a time, not long ago, when he woke on the streets of Mombasa, the nights before a blur of substance use and poor choices. Whether he contracted Hepatitis B through unprotected sex or shared needles in those years remains unclear—the virus does not announce its entry. What matters is that he eventually sought testing, and when the diagnosis came back positive, his sister Aziza, a medical professional now living in the United States, pushed the family to investigate further. They discovered not just the virus, but cancer already growing in his liver. Because the family had resources, they could move quickly. They raced against time and found treatment. Omar survived.
Roy was not as fortunate. He learned he carried Hepatitis B at thirty-seven years old and the news shattered him. He knew what the virus meant—he understood the risks—but fear of stigma kept him silent. He told almost no one. By the time he finally confided in his family, the disease had already progressed to liver cancer, and within weeks he was dead. His family stopped telling people the true cause, unable to bear the judgment that seemed to follow the diagnosis. "There is a lot of stigma attached to the condition," they said later, their grief still raw.
Hepatitis B is a viral infection that can exist in two forms: acute, lasting weeks or months, or chronic, persisting for life. It spreads through blood-to-blood contact, sexual transmission, mother-to-child transfer during birth, and even through shared personal items like razors and toothbrushes. Unsterilized tattoo needles have been a vector. Dr. Andrew Odhiambo, a cancer specialist at Nairobi Hospital who treats patients with liver disease, explained that many people carry the virus without knowing it, their blood circulating the pathogen while they feel perfectly well. But for others, the virus becomes a slow-burning fuse. It damages the liver, sometimes progressing to cirrhosis, sometimes leading directly to cancer. Once liver cancer develops, the prognosis darkens dramatically. Most patients survive between three and six months. Some reach a year. The treatments that work for other cancers—chemotherapy—fail here. Doctors turn instead to immunotherapy and targeted drugs, but the window is narrow.
Kenya reports between nine hundred and one thousand new cases of liver cancer each year, making it the thirteenth most common cancer in the country. Yet most Kenyans do not know their status. The vaccination campaign that began in 2001 reached many children born that year and after, but coverage was not universal. Those born in 2002 onward are largely protected. But millennials and Generation X—people now between twenty-seven and forty years old—largely missed the vaccine. They are the vulnerable cohort. Dr. Odhiambo said revaccination is safe and recommended for anyone uncertain of their immunity.
The real tool for saving lives is surveillance. Countries like South Africa and Egypt have built mandatory national screening programs where people known to carry the virus undergo ultrasounds and blood tests every year. Early detection through these programs allows doctors to catch cancer before it spreads, creating opportunities for surgery or transplantation. Kenya has no liver transplant program yet, though the Kenyatta National Hospital has begun planning one and has trained surgeons ready to perform the operations. Without surveillance, without knowing who carries the virus, the disease remains invisible until it is too late. "Hepatitis B is a silent virus," Dr. Odhiambo said. "It is a silent killer." Patients who survived have told him they wish they had known their status earlier. They wish they had had the chance to act. Kenya has the knowledge and the medical capacity to change this trajectory. What it lacks is the will to mount a nationwide campaign, to test its population, and to build the infrastructure to save the lives that early detection could preserve.
Notable Quotes
There is a lot of stigma attached to the condition. Some people gave us the side eye, so we stopped telling people his real cause of death altogether.— Roy's family, on the social burden of Hepatitis B diagnosis
If you are known to be Hepatitis B positive, you could be in a surveillance programme where every year you undergo ultrasounds and blood tests. You will never catch it early if you are not in a surveillance programme.— Dr. Andrew Odhiambo, cancer specialist at Nairobi Hospital
The Hearth Conversation Another angle on the story
Why does Hepatitis B feel so different from other diseases people talk about?
Because it doesn't announce itself. You can carry it for years feeling fine, then suddenly you're dying of cancer. There's no warning system built in.
And the stigma—why does a virus carry shame the way it does?
Because of how it spreads. Sexual contact, blood exposure, shared needles. People associate it with behaviors they've been taught to judge. Roy died without telling people the truth because he feared that judgment more than the disease itself.
But the vaccine exists. Why aren't more adults protected?
The campaign happened in 2001, but it wasn't universal. Then it stopped. An entire generation—millennials and Gen X—fell through the gap. No one went back to vaccinate them as adults.
So it's a policy failure, not a medical one.
Exactly. The medicine works. The surveillance programs work—South Africa and Egypt proved that. Kenya just hasn't built the system yet. It's a choice, not a limitation.
What would change if people knew their status?
Everything. Early detection through screening means surgery, transplant, survival. Late detection means three to six months. The difference between knowing and not knowing is often the difference between living and dying.